Development and validation of a nomogram for predicting postoperative survival in patients with multifocal hepatocellular carcinoma

Postoperative antiviral treatment for patients with M-HCC, aimed at enhancing immune function and protecting liver function, has been shown to extend patient survival. Simultaneously, factors such as Child-Pugh, age, and Cirrhosis in patients with M-HCC have been associated with a decrease in postoperative survival time.